𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity

✍ Scribed by Julia K. Bar; Piotr Grelewski; Andrzej Popiela; Leszek Noga; Jerzy Rabczyñski

Book ID
113959437
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
453 KB
Volume
95
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ki-67 staining in benign, borderline, ma
Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: Correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D
✍ Sonja C. Henzen-Logmans; Elly J. H. Fieret; Els M. J. J. Berns; Maria E. L. van 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 652 KB

Ki-67 immunoreactivity was studied in relation to immunohistochemically assessed expression of epidermal-growth-factor receptor (EGFR), estrogen receptor (ER) progesterone receptor (PgR) and cytosolic levels of cathepsin D in advanced human ovarian adenocarcinomas, borderline and benign cystadenomas

Expression of urokinase-type plasminogen
Expression of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in benign, borderline, malignant primary and metastatic ovarian tumors
✍ Maria E. L. van der Burg; Sonja C. Henzen-Logmans; Els M. J. J. Berns; Wim L. J. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 620 KB

Elevated levels of expression of the urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 have shown to be related to poor prognosis in a variety of cancer types. In the present study, cytosolic levels of uPA and PAI-1 were determined with enzyme-linked immunosorbent assays in cytosols